4The European Agency for the Evaluation of Medicinal Products, Veterinary Medicines and Inspections,Guidance for the Conduct of Efficacy Studies for lntramammary Products fbr use in Cattle EMEA/CVMP/344/99-Final-P. ev. 1.
5CVM GF #49 Target Animal Safety And l)rug EtTectiveness Studies fnr Anti-Microbial Bovine Mastitis Products(Lactating and Non-Lactating Cow Products).
二级参考文献25
1Allan M J,Thomas E. Pharmacokinetics of cefquinome after parenteral administration of an aqueous solution in the horse[J]. J Vet Pharmacol Therap, 2003,26 (1): 82-307.
2CVMP(Committee for Veterinary Medicial Products), 1995,Cefquinome Summary Report,EMEA/MRL/005/95.
3Cefquinome safety and toxicological data, Obiettivi-e-Documenti. -Veterinari. 1996,17:444-445.
4CVMP (Committee for Veterinary Medicial Products), 1998, Cefquinome Summary Report-1,EMEA/MRL/405/98.
5CVMP (Committee for Veterinary Medicial Products), 1999, Cefquinome Summary Report-2,EMEA/MRL/545/99.
6Shpigel N Y, Schmid P. Treatment of acute mastitis with cefquinome[J]. Tierarztliche Praxis, 1997,25 (3): 200-206.
7Winter P, Baumgartner W, Barillet F, et al. Sensitivity of mastitis pathogens of ewes to antimicrobial drugs [J]. Proceedings of the Sixth International Symposium on the Milking of Small Ruminants, 1999,196-198.
8Pengov A. Treament of clinical and subclinical mastitis cases with Cobactan[J]. Veterinarske Novice (Slovenia), 2001,27 (4): 145-148.
9Navetat H, Griers P, Lancar R, et al. The efficacy of cefquinome in the treatment of infectious enzootic pneumonia in young cattle[J]. Bulletin Des G T V,1996, (1) :21-25.
10Scott P R. A field study of respiratory disease affecting housed beef calves in the UK[J]. Cattle Practice, 1995,3:393-401.
